Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Steve Miller
Pharma
Bayer, Loxo pick up FDA nod for new $400K cancer drug
Bayer and its partner Loxo Oncology picked up FDA approval for their novel "tissue agnostic" TRK inhibitor Vitrakvi.
Eric Sagonowsky
Nov 27, 2018 12:09pm
Express Scripts takes credit for Gilead's generics move
Sep 25, 2018 11:15am
Can Praluent's new formulary exclusive jump-start sales?
May 2, 2018 9:04am
What's your Aimovig rollout plan, Amgen?
Apr 25, 2018 11:35am
What does Cigna's $54B Express Scripts buy mean for pharma?
Mar 8, 2018 11:45am
Novartis' CAR-T, other gene therapies need ‘new payment model’
Sep 22, 2017 11:30am
